| Business Summary | | The
Female
Health
Company
(FHC)
manufactures,
markets
and
sells
the
Female
Condom,
the
only
FDA-approved
product
under
a
woman's
control
that
can
prevent
unintended
pregnancy
and
sexually
transmitted
diseases
(STDs),
including
HIV/AIDS.
The
product
has
been
specifically
developed
and
approved
by
regulatory
agencies
in
the
United
States,
the
European
Union,
Japan
and
The
People's
Republic
of
China,
among
others,
for
the
prevention
of
the
transmission
of
HIV/AIDS
through
sexual
contact. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | The
Female
Health
Company
markets,
manufactures,
and
sells
the
female
condom,
the
only
FDA-approved
product
under
a
woman's
control
which
can
prevent
unintended
pregnancy
and
sexually
transmitted
diseases,
including
HIV/AIDS.
For
the
six
months
ended
3/31/01,
revenues
rose
21%
to
$2.7
million.
Net
loss
applicable
to
Common
decreased
54%
to
$1.1
million.
Results
reflect
increased
unit
sales
shipped
to
domestic
customers,
lower
amortization
costs
and
lower
debt
levels. Recent Earnings Announcement For
the
3
months
ended
06/30/2001,
revenues
were
2,296;
after
tax
earnings
were
45. (Preliminary; reported in thousands of dollars.) | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| O. Parrish, 67 Chairman,
CEO | $90K | Mary Leeper, Ph.D., 60 Pres
and COO | 225K | Michael Pope, 44 VP | -- | Mitchell Warren, 34 VP
- International Affairs | -- | Jack Weissman, 53 VP
- Trade Sales | -- | Dollar amounts are as of 30-Sep-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|